ChatGPT to be utilized in new medical imaging app for patients

AI chatbot ChatGPT is making its official debut in medical imaging by way of a new app that can be utilized by anyone with a smartphone. 

Earlier in April, imaging IT leader RamSoft announced that it would soon be introducing a patient-centric medical imaging app that is powered by AI program ChatGPT. The patient portal app is called Blume; it is intended to help streamline the process of sharing medical imaging and reports between patients and providers while also offering patients opportunities to seek information regarding imaging procedures and results. 

The ChatGPT integration will allow patients to ask the chatbot questions about their medical imaging exams and procedures and receive plain language answers in real-time. The hope is that it will improve outcomes by better informing patients about their medical care plan. 

Vijay Ramanathan, RamSoft CEO, commented on the new feature in a prepared statement. 

“Two key factors underline the importance of addressing patient centricity,” Ramanathan said. “First, leveraging the widespread adoption of smartphones to enhance doctor-patient communication and second, complying with the 21st Century Cures Act which mandates that healthcare providers share images and reports with patients.” 

Additional features of the Blume app include self-scheduling and managing appointment requests, the ability to complete and submit intake forms, insurance verification and medical image sharing between patients and providers. 

The app is available on Android and iOS devices and can be downloaded from Google Play and Apple’s App store. 

RamSoft made the announcement at HIMSS 2023. The app has not yet gone live, but RamSoft is offering personal online demos of it. For more information, click here.

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.